LUV00996 The provision of services for formulation development, clinical batch manufacture and distribution of the active pharmaceutical ingredient (API), Resveratrol: the COLO-PRE...
LUV00996 The provision of services for formulation development, clinical batch manufacture and distribution of the active pharmaceutical ingredient (API), Resveratrol: the COLO-PREVENT study
Buyer
University of Leicester
Value
£1,057,433
Published
14 Oct 2021
Closes
6 May 2021
Procurement details
Source
Find a Tender
Region
Leicester
Procurement method
Open
Category
Services
Contract starts
Not provided
Contract ends
Not provided
CPV classifications
73000000
Research and development services and related consultancy services
Lots
Lot 1 LUV00996 The provision of services for formulation development, clinical batch manufacture and distribution of the active pharmaceutical ingredient (API), Resve...
£1,057,433
LUV00996 The provision of services for formulation development, clinical batch manufacture and distribution of the active pharmaceutical ingredient (API), Resveratrol: the COLO-PREVENT study. COLO-PREVENT will assess whether intervention with the API resveratrol is able to affect recurrence of colorectal adenomas within the NHS Bowel Cancer Screening Program...
Delivery: United Kingdom
Documents
No document metadata is available for this public record.
Contains public sector information licensed under the Open Government Licence v3.0.